Charles Schwab Investment Management Inc Ocugen, Inc. Transaction History
Charles Schwab Investment Management Inc
- $527 Billion
- Q4 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Ocugen, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 860,244 shares of OCGN stock, worth $524,748. This represents 0.0% of its overall portfolio holdings.
Number of Shares
860,244
Previous 766,956
12.16%
Holding current value
$524,748
Previous $759,000
9.35%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding OCGN
# of Institutions
123Shares Held
68.6MCall Options Held
478KPut Options Held
253K-
Black Rock Inc. New York, NY17.9MShares$10.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.6MShares$10.1 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA6.59MShares$4.02 Million0.0% of portfolio
-
State Street Corp Boston, MA5.87MShares$3.58 Million0.0% of portfolio
-
Gmt Capital Corp Atlanta, GA2.45MShares$1.5 Million0.1% of portfolio
About Ocugen, Inc.
- Ticker OCGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 216,566,000
- Market Cap $132M
- Description
- Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...